Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial. LMJHCR 2026, 4 (1), 1-9. https://doi.org/10.61919/061x6w21.